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Abstract 
 
Liver ischemia-reperfusion (I/R) injury is one of the most serious complications of 
hepatic surgery. In I/R, activated Kupffer cells cause platelet adhesion to sinusoidal 
endothelium as well as neutrophils and cause liver dysfunction. The aim of this study 
was to evaluate platelet dynamics in the hepatic microcirculation after I/R by intravital 
microscopy (IVM) and to clarify the relationship between platelet adhesion and 
neutrophil activation. Male Sprague-Dawley (SD) rats were divided into two groups: the 
control (administration of saline) group and the sivelestat group in which neutrophil 
activation was suppressed by sivelestat before I/R. The number of adherent platelets in 
sinusoid was observed up to 120 minutes after I/R by IVM. Samples of liver tissue and 
blood were taken for examination of histological findings, liver enzymes and 
inflammatory cytokines. The number of adherent platelets was significantly increased 
after I/R in both groups. Compared with the control group, the number of adherent 
platelets significantly decreased after hepatic I/R in the sivelestat group. Moreover, 
sivelestat improved changes of histological findings and elevation of liver enzymes. 
However, there was no significant difference in inflammatory cytokines of TNF-α, 
IL-1β and IL-6. Platelet adhesion in the sinusoid is associated with liver dysfunction 
after I/R as well as neutrophils. Activated neutrophils induce the platelet adhesion in the 
sinusoid of the liver. 
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Introduction 
 
Liver injury caused by hepatic ischemia-reperfusion (I/R) is a major complication of 
liver resection and liver transplantation. The disturbance of hepatic microcirculation is 
considered the primary cause of hepatic I/R injury[1]. An excessive inflammatory 
response is a critical component of hepatic I/R injury. Previous studies have reported 
that there are two distinct phases of liver injury after warm hepatic I/R[2,3]. The early 
phase is characterized by activation of Kupffer cells (KCs) which generate reactive 
oxygen species and aggravate the early injury occurring within 120 minutes[4,5]. 
Neutrohphils accumulate in the liver and contribute to hepatocyte injury in the late 
phase, which appears more than 6 hours after reperfusion[2,3]. 
A neutrophil elastase inhibitor, sivelestat, has been approved as a therapeutic drug for 
acute lung injury associated with systemic inflammatory response syndrome[6]. In the 
previous report we demonstrated that after the induction of liver ischemia, sivelestat 
attenuated the number of accumulated neutrophils and suppressed I/R injury[7]. 
Recently some studies have focused on the role of platelets in hepatic I/R. Activated 
platelets produce proinflammatory mediators, such as chemokines and cytokines[8,9]. 
Sindram et al. reported that without platelets and leukocytes, the function of KCs was 
decreased and I/R injury was suppressed[10]. However, the relationship between 
platelets and neutrophils is still unclear. The aim of this study was to investigate platelet 
adhesion on I/R of the livers in vivo using IVM and the relationship between platelet 
adhesion and neutrophil activation. 
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Materials and Methods 
 
Animals 
 
Male Sprague-Dawley (SD) rats, weighing 250 to 300 g, were obtained from CLEA 
Japan (Tokyo, Japan). Animal experiments were carried out in a humane manner after 
receiving approval from the Institutional University Experiment Committee of the 
University of Tsukuba, and in accordance with the Regulation for Animal Experiments 
in the university and Fundamental Guideline for Proper Conduct of Animal Experiment 
and Related Activities in Academic Research Institutions under the jurisdiction of the 
Ministry of Education, Culture, Sports, Science, and Technology. 
 
Experimental groups 
 
Total warm hepatic ischemia was induced for 20 minutes by clamping the portal triad. 
Animals were divided into two groups as follows: (A) a control group, in which saline 
was continuously infused via the jugular vein for 60 minutes 10 ml/kg/h before hepatic 
ischemia (n=6), and (B) the sivelestat group, in which 10 mg/kg/h sivelestat (Ono 
Pharmaceutical Co., Osaka, Japan) was continuously infused via the jugular vein 60 
minutes before hepatic ischemia (n=6). The dose of sivelestat described above was 
determined by previous reports[7,11]. Sivelestat, ONO-5046; N- [2-(4- 
[2,2-dimethylpropionyloxy] phenylsulphonyl-amino)benzoyl] was dissolved in saline 
and the pH was modulated to 7.8 using Na2 CO3. All animals also received a 
continuous infusion of saline via the jugular vein to prevent dehydration (10 ml/kg/h). 
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Administration of sivelestat and saline was started 60 minutes before hepatic ischemia 
to achieve an adequate blood concentration and continued up to 120 minutes after 
reperfusion[12]. Platelet dynamics and hepatic microcirculation were observed just 
before ischemia and at 30, 60, and 120 minutes after reperfusion (Fig.1). 
 
Surgical Procedure 
 
Under anesthesia with intraperitoneal sodium pentobarbital (50 mg/kg), the animals 
were tracheotomized. To reduce spontaneous breathing, the animals were ventilated 
mechanically (KN-55; Natsume Co. Ltd., Tokyo, Japan). When spontaneous breathing 
interfered with mechanical ventilation, additional pentobarbital (10 mg/kg) was 
administered intravenously. The animals were placed in a supine position on a heated 
pad to maintain a rectal temperature of 37°C. To monitor arterial blood pressure and 
allow continuous infusion of sivelestat and saline, polyehylen catheters (PE-50, 
0.58/0.96 mm internal/external diameter; Becton Dickinson, Sparks, MD) were inserted 
into the left carotid artery and left jugular vein. After laparotomy had been performed by 
a transversal incision, the ligaments around the liver were dissected to mobilize the left 
lobe. At the same time, the hepatoduodenal ligament was taped in preparation of 
clamping later. The left lobe was exteriorized on a plate specially designed to minimize 
movement caused by respiration and covered with a cover glass. After 60 minutes of 
continuous sivelestat or physiological saline infusion, intravital fluorescence 
microscopy (IVM) was performed as a baseline study. Hepatic ischemia was then 
induced by portal triad clamping, i.e., hepatic artery, portal vein, and bile duct, by 
means of a microclip (Aesculap, Tuttlingen, Germany) for 20 minutes. IVM was 
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performed at 30, 60, and 120 minutes after reperfusion. Blood samples were taken for 
the analysis of enzyme activities in serum at the same time as IVM. At the end of the 
experiments, liver tissue was taken for histological examination. 
 
Platelet Preparation 
 
Platelets were isolated from whole blood of syngeneic rats and labeled with 
rhodamine-6G (50 µL/ml whole blood: R-4127; Sigma, St. Louis, MO), as described by 
Massberg et al[13]. Briefly, the collected blood was diluted with buffer after the 
addition of prostaglandin E1 and rhodamine-6G. After 2-cycle centrifugation, 
fluorescent platelets were resuspended in PBS. In this study, a total amount of 1 x 108 
fluorescence-labeled platelets, approximately 1% of all circulating platelets in the 
recipient rat, were injected through the left carotid artery at 5 minutes before IVM. 
 
Intravital Fluorescence Microscopy (IVM) 
 
IVM was performed using a modified microscope (BX30 FLA-SP; Olympus, Tokyo, 
Japan) with a 100 W mercury lamp attached to a filter block. The hepatic 
microcirculation was recorded by means of a CCD camera (C5810; Hamamatsu 
Photonics, Hamamatsu, Japan) and a digital video recorder (GV-D1000 NTSC; Sony, 
Tokyo, Japan) for off-line analysis. Using objective lenses (10 x 0.3 to 20 x 0.7; 
Olympus, Tokyo, Japan), a final magnification of 325x to 650x was achieved on the 
video screen. To assess sinusoidal perfusion, sodium fluorescein (2 x 10-3 M/kg, 
F-6377; Sigma, St. Louis, MO) was injected via the jugular catheter. Rhodamine-6G 
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labeling platelets were infused intra-arterially just before ischemia and at 30, 60, and 
120 minutes after reperfusion, and 7 to 10 randomly chosen acini were visualized. 
 Quantitative assessment of microcirculatory parameters was performed offline 
using WinRoof image software (version 5.0; Mitani Shoji, Tokyo, Japan). 
 
Microcirculatory Analysis 
 
The following two parameters were analyzed. (1) Number of adherent platelets; 
platelets firmly attached to the endothelium within the sinusoid for longer than 20 
seconds. The number of adherent platelets was counted in scanned acini. The results 
were expressed as the number of adherent platelets per field (1 field = approximately 
0.2 mm2). (2) Zonal distribution of platelets (zone 1 + zone 2 and zone 3). 
 
Histological Analysis 
 
After 120 minutes of reperfusion, liver tissues were obtained from each group, fixed 
with 10% formaldehyde, and embedded in paraffin. Thin sections (4µm) were prepared 
and stained with hematozylin (HE). Tissue damage was evaluated in five randomly 
selected high-power fields (x 400). 
 
Biochemical Assays 
 
As a marker of liver deterioration, the activities of alanine transaminase (ALT) and 
lactate dehydrogenase (LDH) were measured in serum using a Drychem 7000V auto 
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analyzer (Fuji Film, Tokyo, Japan). 
Serum was stored at -80°C until use for cytokine determination. Levels of tumor 
necrosis factor (TNF) α, interleukin (IL) 1β, and IL-6 were measured using commercial 
enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN). 
 
Statistical Analysis 
 
All data are expressed as mean ± standard deviation (SD). The Mann-Whitney test 
and analysis of variance (ANOVA) were used, followed by Scheffe’s test. P values 
<0.05 were considered statistically significant. 
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Results 
 
Number and Zonal Distribution of Adherent Platelets in Acini 
 
In the control group, the number of adherent platelets was increased after reperfusion 
(P<0.001). This continued in proportion to the duration of reperfusion up to 120 minutes 
(Fig.2A and B). In the sivelestat group, platelet adhesion was significantly prevented 
compared with the control group (Fig. 2A and B). In the control group approximately 
67% of adherent platelets were located in zones 1 and 2 at 120 minutes after reperfusion. 
In the sivelestat group, the number of adherent platelets in zones1 and 2 was 
significantly decreased compared with the control group (Fig. 3). 
 
Histological Findings 
 
In the control group vacuolation of hepatocyte and sinusoidal narrowing were 
demonstrated histologically after 120 minutes of reperfusion (Fig. 4). These findings 
were not recognized in the sivelestat group.  
 
Serum Liver Enzymes and Cytokines Levels 
 
The number of white blood cell (WBC) and platelet (PLT) in the blood was not 
significantly different between the control and sivelestat groups within 120 minutes 
after I/R (Data are not shown). However, serum ALT and LDH reflecting parenchymal 
injury significantly increased after I/R in the control group. In the sivelestat group, ALT 
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and LDH after I/R were significantly lower than in the control group (Fig.5). In addition, 
the concentration of serum TNF-α, IL-1β, and IL-6 was not significantly different 
between the two groups (Table.1). 
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Discussion 
 
The role of neutrophils in hepatic I/R has been investigated in many studies[1,2,5]. 
Recently, some studies have focused on the role of platelets in the stress condition of the 
liver[14-16]. Platelets have a pivotal function of biological improvement or 
deterioration in the liver stress[17]. Some reports demonstrated that platelets contribute 
toward the prevention of liver fibrosis and promote liver regeneration after 
hepatectomy[16-18]. Conversely, several reports have demonstrated the contribution of 
platelets on hepatic I/R injury[8,9,14]. In this study, we evaluated the dynamics of 
platelets in liver microcirculation and tried to clarify the mechanism of platelet adhesion 
after I/R. As a result, adherent platelets were significantly increased after I/R and 
platelet adhesion was induced by neutrophil activation. 
Hepatic I/R stimulated KCs and neutrophils and the interaction between these cells 
also reactivated themselves[9,19]. Activated neutrophils released neutrophil elastase and 
adhered to sinusoidal endothelial cells and migrated to parenchymal cells[1,3,5]. In 
addition, platelets also have a correlation with hepatic I/R[14]. Platelet adhesion was 
increased after hepatic I/R[14,21]. Neutrophils and platelets synergistically exacerbate 
sinusoidal endothelial cell apoptosis in hepatic I/R and KCs alone did not cause the 
hepatic I/R injury[10]. In our previous study we demonstrated that the number of 
adherent platelets was suppressed by the elimination of KCs[14]. The present study 
revealed that zonal distribution of adherent platelets was mostly located in zones 1 and 2. 
The distribution of platelets was similar to that of KCs[14]. It is likely that there is a 
correlation between adherent platelets and KCs. In the control group, vacuolation of 
hepatocyte and sinusoidal narrowing were demonstrated after I/R on histological 
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examination, but in the sivelestat group these findings were not detected. Sivelestat 
suppressed the number of adherent platelets and elevation of liver enzymes. Adherent 
platelets are likely to be related to neutrophil activation. Therefore, platelets also 
induced hepatic microvascular dysfunction as well as neutrophils and KCs[1,3,5].  
Activated neutrophils cause conversion of xanthine dehydrogenase to xanthine 
oxidase in endothelial cells, and the mechanism is associated with the cytotoxic effect of 
activated neutrophils[22]. Sivelestat is a highly selective neutrophil elastase 
inhibitor[23]. Some studies reported that sivelestat was implicated in the conversion 
from xanthine dehydrogenase to xanthine oxidase during ischemia[11,22]. Kusner et al. 
reported that neutrophil elastase promoted neutrophil activation[24]. Administration of 
sivelestat before induction of ischemia protects against hypoxia-induced neutrophil 
activation. This so-called “neutrophil priming” has been considered to be an 
indispensable step in reperfusion injury[25,26]. Our previous study demonstrated that 
administration of sivelestat suppressed the number of adherent neutrophils[7]. Therefore, 
the suppression of neutrophil elastase is likely to attenuate neutrophil priming by 
suppressing xanthine oxidase release after reperfusion. On the other hand, Yamaguchi et 
al. indicated that suppression of inflammatory cytokines was a possible mechanism of 
the neutrophil elastase suppression[27]. However in this study we demonstrated that 
sivelestat did not suppress the inflammatory cytokines but did suppressed the number of 
adherent platelets after I/R. From these findings, it is highly possible that suppression of 
neutrophil activation by sivelestat attenuated the number of adherent platelets in 
sinusoid. 
In this study, sivelestat did not suppress the levels of serum cytokines such as TNF-α, 
IL-1β, and IL-6. Activated KCs released a large amount of both proinflammatory and 
13 
 
13 
 
anti-inflammatory mediators after I/R, i.e., TNF-α, IL-1, IL-6, PG, IL-10 and IL-13[9]. 
In general, following the activation of KCs, platelets react and immediately accumulate 
in the hepatic sinusoids[3]. The present study demonstrated that sivelestat did not 
suppress the levels of inflammatory cytokines. It is likely that there was no correlation 
between KCs and administration of sivelestat. Our results indicated that platelet 
adhesion was induced by neutrophil activation without KCs. 
To reduce hepatic I/R injury, various agents and methods have been reported[11,20]. 
However, they are not suitable for clinical use due to toxicity or other side effects. 
Sivelestat actually suppressed the number of adherent neutrophils[7] and platelets and 
sivelestat prevented apoptosis of sinusoidal endothelial cells after hepatic I/R. Therefore, 
pre-administration of sivelestat would be effective in the prevention against liver injury. 
 
Conclusion 
 
Adhesion of platelets was involved in hepatic I/R injury. The activation of 
neutrophils was strongly associated with adherent platelets. Sivelestat appears to be 
useful for hepatic I/R in a clinical setting. 
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Figure legend 
Figure.1: Experimental groups.  
Total warm hepatic ischemia was performed for 20 min by clamping the portal triad in 
each group. Animals were divided into two groups: control group, and sivelestat group. 
A total of 1 x 108 fluorescence-labeled platelets, approximately 1% of all circulating 
platelets in the recipient rat, were injected through the left carotid artery before 5 min of 
IVM. 
 
Figure.2: Platelet dynamics in sinusoid.  
(A) In the sivelestat group, the number of adherent platelets was significantly decreased 
compared with the control group before induction of ischemia and at 30 min after 
reperfusion and with duration of reperfusion. ∗P<0.001; versus the control group (n=6). 
(B) Video images of adherent platelets in acini 120 min after reperfusion. Many 
platelets adhered in the sinusoid in the control group. However, in the sivelestat group 
only a few platelets were recognized. 
 
Figure.3: Zonal distribution of adherent platelets.  
In the control group, approximately 67% of adherent platelets were located in zones1 
and 2 at 120 min after reperfusion. ∗P<0.001; versus zones1 and 2 in the control group; 
∗∗P<0.005; versus zones 1 and 2 in the control group; ∗∗∗P<0.005; versus zone 3 in the 
control group (n=6).  
 
 
 
Figure.4: Histological findings.  
In the control group, vacuolation of hepatocyte and sinusoidal narrowing (arrow head) 
were demonstrated after 120 min of reperfusion on histological examination. In the 
sivelestat group, these findings were not recoginized (HE stain x 400). 
 
Figure.5: Serum liver enzymes.  
Serum ALT and LDH, reflecting hepatic parenchymal injury, increased after reperfusion 
in the control group. ∗P<0.05; versus before induction of ischemia in the control group. 
In the sivelestat group serum ALT and LDH significantly decreased after reperfusion. 
∗∗P<0.05; versus the control group (n=6).  
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sivelestat group - 54.5±43.1 142.6±84.3 237.2±100.2
P-value 0.34 0.11 0.23 0.26
IL-1β control group 26.6±28.6 38.8±34.9 71.2±50.6 149.7±71.2
sivelestat group 28.5±13.2 23.9±16.9 58.3±24.20 225.7±151.6
P-value 0.43 0.15 0.26 0.11
IL-6 control group 67.8±34.5 220.91±179.8 1419.7±1575.2 4000.5±2406.5
sivelestat group 74.0±33.8 519.1±617.3 2551.7±2213.9 4401.1±2250.5
P-value 0.36 0.11 0.13 0.37
Table.1: Serum cytokines levels at before ischemia and after reperfusion in both groups.
No significant differences were found between control and sivelestat groups.
pre, before induction of ischemia
 
1 
 
References 
1. H Jaeschke. Mechanisms of reperfusion injury after warm ischemia of the liver. J 
Hepatobiliary Pancreat Surg 1998;5:402-408. 
2. H Jaeschke, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and 
ischemia-reperfusion injury in rat liver. Am J Physiol 1991;260:G355-362. 
3. Arii S, Teramoto K, Kawamura T. Current progress in the understanding of and 
therapeutic strategies for ischemia and reperfusion injury of the liver. J 
Hepatobiliary Pancreat Surg 2003;10:189-194. 
4. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver 
disease. Liver Int 2006;26:1175–1186. 
5. H Jaeschke. Mechanism of Liver Injury.II Mechanism of neutrophil-induced liver 
cell injury during hepatic ischemia-reperfusion and other acute inflammatory 
conditions. Am J Physiol Gastrointest Liver Physiol 2006;290:G1083-1088. 
6. Tamakuma S, Ogawa M, Aikawa N, Kubota T, Hirasawa H, Ishizuka A, Taenaka N, 
Hamada C, Matsuoka S, Abiru T. Relationship between neutrophil elastase and 
acute lung injury in humans. Pulm Pharmacol Ther 2004;17:271-279. 
7. Nakano Y, Kondo T, Matsuo R, Murata S, Fukunaga K, Ohkohchi N. Prevention of 
leukocyte activation by the neutrophil elastase inhibitor, sivelestat, in the hepatic 
microcirculation after ischemia-reperfusion. J Surg Res 2009;155:311-317. 
8. Khandoga A, Biberthaler P, Messmer K, Krombach F. Platelet-endothelial cell 
interactions during hepatic ischemia-reperfusion in vivo: a systematic analysis. 
Microvasc Res 2003;65:71-77. 
9. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. 
Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 
 
2 
 
2008;147: 153-159. 
10. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Synergism between 
platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic 
rat liver: a Kupffer cell-mediated injury. FASEB J 2001;15:1230-1232. 
11. Kotake Y, Yamamoto M, Matsumoto M, Morisaki H, Takeda J. Sivelestat, a 
neutrophil elastase inhibitor, attenuates neutrophil priming after hepatoenteric 
ischemia in rabbits. Shock 2005;23:156-160. 
12. Fujimoto H, Shintani T, Takamoto M, Yamamoto R, Hiraku S. Studies on the 
metabolic fate of neutrophil elastase inhibitor ONO-5046Na (5): Plasma 
concentration-profile after intravenous bolus administration or intravenous infusion 
to rats and dogs. Yakubutudoutai 1998;13:28-35. 
13. Massberg S, Eisenmenger S, Enders G, Krombach F, Messmer K. Quantitative 
analysis of small intestinal microcirculation in the mouse. Res Exp Med (Berl) 
1998;198:23-35. 
14. Nakano Y, Kondo T, Matsuo R, Hashimoto I, Kawasaki T, Kohno K, Myronovych 
A, Tadano S, Hisakura K, Ikeda O, Watanabe M, Murata S, Fukunaga K, Ohkohchi 
N. Platelet dynamics in the early phase of postischemic liver in vivo. J Surg Res 
2008;149:192-198. 
15. Myronovych A, Murata S, Chiba M, Matsuo R, Ikeda O, Watanabe M, Hisakura K, 
Nakano Y, Kohno K, Kawasaki T, Hashimoto I, Shibasaki Y, Yasue H, Ohkohchi N. 
Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol  
2008;49:363-372. 
16. Watanabe M, Murata S, Hashimoto I, Nakano Y, Ikeda O, Aoyagi Y, Matsuo R, 
Fukunaga K, Yasue H, Ohkohchi N. Platelets contribute to the reduction of liver 
 
3 
 
fibrosis in mice. J Gastroenterol Hepatol 2009;24:78-89. 
17. Pereboom IT, Lisman T, Porte RJ. Platelets in liver transplantation: friend or foe? 
Liver Transpl 2008;14:923-931. 
18. Murata S, Matsuo R, Ikeda O, Myronovych A, Watanabe M, Hisakura K, Nakano Y, 
Hashimoto I, Ohkohchi N. Platelets promote liver regeneration under conditions of 
Kupffer cell depletion after hepatectomy in mice. World J Surg 2008;32:1088-1096. 
19. Kobayashi A, Imamura H, Isobe M, Matsuyama Y, Soeda J, Matsunaga K, 
Kawasaki S. Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in 
ischemia-reperfusion injury of rat liver. Am J Physiol Gastrointest Liver Physiol 
2001;281:G577-585. 
20. Khandoga A, Hanschen M, Kessler JS, Krombach F. CD4+ T cells contribute to 
postischemic liver injury in mice by interacting with sinusoidal endothelium and 
platelets. Hepatology 2006;43:306-315. 
21. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion 
injury-a fresh look. Exp Mol Pathol 2003;74:86-93. [PubMed: 12710939] 
22. Phan SH, Gannon DE, Ward PA, Karmiol S. Mechanism of neutrophil-induced 
xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: 
evidence of a role for elastase. Am J Respir Cell Biol 1992;6:270-278. 
23. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO-5046, a 
novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 
1991;177:814-820. 
24. Kusner DJ, Aucott JN, Franceschi D, Sarasua MM, Spangnuolo PJ, King CH. 
Protease priming of neutrophil superoxide production. Effects on membrane lipid 
order and lateral mobility. J Biol Chem 1991;266:16465-16471. 
 
4 
 
25. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW. Functional 
inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody 
protects against ischemia-reperfusion injury in rat liver. Hepatology. 
1993;17:915-923. 
26. Yamada K, Horikawa N, Matsui K, Yamamoto S, Kawamura N, Ohashi N. 
Inhibitory effect of SM-20550, an Na/H exchange inhibitor, on accumulation of 
leukocytes in ischemia and reperfusion. Naunyn Schmiedebergs Arch Pharmacol 
2001;363:597-603. 
27. Yamaguchi Y, Akizuki E, Ichiguchi O, Matsumura F, Goto M, Miyanari N, Mori K, 
Yamada S, Ogawa M. Neutrophil elastase inhibitor reduces neutrophil 
chemoattractant production after ischemia-reperfusion in rat liver. Gastroenterology. 
1997;112:551-560. 
